公告日期：2025-10-22

Huadong Medicine Co., Ltd.

2025 Semi-annual Report

August 20, 2025

Section I Important Notes, Table of Contents and Definitions

The Board of Directors, directors, and senior management of Huadong
Medicine Co., Ltd. (hereinafter referred to as the "Company") hereby
guarantee that the information presented in this report is authentic, accurate
and complete, and free of false records, misleading statements or material
omissions, and shall undertake individual and joint legal liabilities.

Lv Liang, the Company’s legal representative and the officer in charge of
accounting, and Qiu Renbo, head of the accounting department (accounting
manager) hereby declare that the financial statements in this semi-annual
report are authentic, accurate, and complete.

All directors have attended the Board of Directors meeting to review this
semi-annual report.

The future plans, development strategies and other forward-looking
statements in this semi-annual report shall not be considered as a substantial
commitment of the Company to investors. Investors and related parties should
be fully aware of the risks, and understand the differences between plans,
forecasts and commitments.

The risks the Company faces in operation include industry policy and
product price reduction risk, new drug R&D risk, investment and M&A risk
and exchange rate fluctuation risk. For details, please refer to "X. Risks faced
by the Company and countermeasures" in "Section III. Management's
Discussion and Analysis". Therefore, investors are kindly reminded to pay
attention to possible investment risks.

The dividend distribution scheme approved at the meeting of the Board of
Directors is as follows: On the basis of 1,754,021,048.00 shares—derived by
excluding 56,000.00 restricted stock (pending repurchase and cancellation)
from the existing total share capital of 1,754,077,048.00 shares, RMB 3.50
(before tax) of cash dividends per ten shares will be distributed to all
shareholders; a ……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。